Skip to content
Free planNo credit card requiredStart writing

preprint · 2022

CD34+ Cell RNP Nucleofection v1

Daniel A. Kuppers

Cited by 0Open access

Abstract

Human CD34+hematopoietic stem and progenitor cells (HSPCs) are a standard source of cells for clinical HSC transplantations as well as experimental xenotransplantation to generate “humanized mice”. To further extend the range of applications of these humanized mice, we developed a protocol to efficiently edit the genomes of human CD34+HSPCs before transplantation. We have optimized nucleofection of sgRNA:Cas9 ribonucleoprotein complexes and are now able to edit a candidate gene in CD34+HSPCs with almost 100% efficiency, and without affecting their potential for engraftment and multilineage differentiation in mice.

Cite this paper

APA 7

Kuppers, D. A. (2022). CD34+ Cell RNP Nucleofection v1. https://doi.org/10.17504/protocols.io.q26g7y541gwz/v1

MLA 9

Kuppers, Daniel A. “CD34+ Cell RNP Nucleofection v1.” 2022, https://doi.org/10.17504/protocols.io.q26g7y541gwz/v1.

Chicago

Kuppers, Daniel A. 2022. “CD34+ Cell RNP Nucleofection v1.” https://doi.org/10.17504/protocols.io.q26g7y541gwz/v1.

Harvard

Kuppers, D.A. (2022) ‘CD34+ Cell RNP Nucleofection v1’. Available at: https://doi.org/10.17504/protocols.io.q26g7y541gwz/v1.

BibTeX
@misc{kuppers2022cd34,
  title = {{CD34+ Cell RNP Nucleofection v1}},
  author = {Kuppers, Daniel A.},
  year = {2022},
  doi = {10.17504/protocols.io.q26g7y541gwz/v1}
}

Made from the index record. Check names, capitalisation and page numbers against the paper. Need another style? AI for Research has over 10,000.